Rehabilitative management of an infant with Pelizaeus-Merzbacher disease: A case report.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
29 May 2020
29 May 2020
Historique:
entrez:
3
6
2020
pubmed:
3
6
2020
medline:
11
6
2020
Statut:
ppublish
Résumé
Pelizaeus-Merzbacher disease (PMD) is an X-linked recessive trait and a rare disease characterized by abnormal myelin formation in the central nervous system. Since Pelizaeus and Merzbacher reported the pathology of PMD in the 1990s most studies have examined pharmacological treatments. No studies have reported the effects of rehabilitation on patients with PMD aimed at improving their functional abilities. We report the first case of improved development after rehabilitation in a patient with Pelizaeus-Merzbacher disease. A 1-month-boy developed focal seizures, nystagmus, and jerky head movements. He was brought to our outpatient clinic for rehabilitation of developmental delay at 11 months of age. He showed hypotonia, nystagmus, and developmental delay of 4 to 5 months in his gross and fine motor ability. Developmental delay in a patient with PMD. A child with PMD was hospitalized 3 times for 3 months and underwent rehabilitation to improve developmental delay. Developmental assessments were conducted before and after each admission for rehabilitation training. Before training, the patient was unable to maintain a sitting position. After the first and second training sessions, his gross motor ability had improved, and he could sit with a mild assist. Fine motor function also improved. Before training, the patient was able to transfer a cube from one hand to the other. After training, he could perform a pincher grasp. Rehabilitation training can help PMD patients achieve maximal function and catch-up in their growth.
Identifiants
pubmed: 32481377
doi: 10.1097/MD.0000000000020110
pii: 00005792-202005290-00022
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e20110Références
Pelizaeus F. Uber eine eigentumliche Form spatischer Lahmungmit Zerebralerscheinungen auf hereditarer Grundlage (multiple Sklerose). Arch Psychiatr Nervenkr 1885;16:698.
Merzbacher L. Gesetzmaessigkeiten in der Vererbung und Verbreitung vershiedener hereditaer-familiaerer Erkrankungen. Arch Rass Ges Biol 1909;6:172–98.
Numata Y, Gotoh L, Iwaki A, et al. Epidemiological, clinical, and genetic landscapes of hypomyelinating leukodystrophies. J Neurol 2014;261:752–8.
Hobson GM, Garbern JY. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. Semin Neurol 2012;32:62–7.
Hobson GM, Kamholz J. PLP1-Related Disorders. Seattle (WA): GeneReviews (R); 1993.
Hudson LD, Puckett C, Berndt J, et al. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. Proc Natl Acad Sci USA 1989;86:8128–31.
Hodes ME, Pratt VM, Dlouhy SR. Genetics of Pelizaeus-Merzbacher disease. Dev Neurosci 1993;15:383–94.
Griffiths I, Klugmann M, Anderson T, et al. Current concepts of PLP and its role in the nervous system. Microsc Res Tech 1998;4:344–58.
Garbern JY. Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis. Cell Mol Life Sci 2007;64:50–65.
Woodward KJ. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease. Expert Rev Mol Med 2008;10:e14.
Torii T, Miyamoto Y, Yamauchi J, et al. Pelizaeus-Merzbacher disease: cellular pathogenesis and pharmacologic therapy. Pediatr Int 2014;56:659–66.
Koeppen AH, Robitaille Y. Pelizaeus-Merzbacher disease. J Neuropathol Exp Neurol 2002;61:747–59.
Seitelberger F. Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol 1995;5:267–73.
Renier WO, Gabreëls FJ, Hustinx TW, et al. Connatal Pelizaeus-Merzbacher disease with congenital stridor in two maternal cousins. Acta Neuropathol 1981;54:11–7.
Mothe AJ, Tator CH. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination. Exp Neurol 2008;213:176–90.
Saher G, Rudolphi F, Corthals K, et al. Therapy of Pelizaeus–Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nat Med 2012;18:1130–5.
Demos Medical, Alexander MA, Matthews DJ, Murphy KP. McMahon M, Pruitt D, Vargus-Adams J. Cerebral Palsy. Pediatric Rehabilitation: Principles and Practice 5th edn2015. 348–9.
Morgan C, Darrah J, Gordon AM, et al. Effectiveness of motor interventions in infants with cerebral palsy: a systematic review. Dev Med Child Neurol 2016;58:900–9.
Novak I, Morgan C, Adde L, et al. Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr 2017;171:897–907.
Reid LB, Rose SE, Boyd RN. Rehabilitation and neuroplasticity in children with unilateral cerebral palsy. Nat Rev Neurol 2015;11:390–400.